Abstract: A subject support includes a fixed portion and a moveable portion coupled to the fixed portion and configured to move along at least one axis relative to the fixed portion, and the coupling includes one or more points of friction that move during movement of the moveable portion and which wear due to at least movement by the moveable portion. The moveable portion receives and supports at least one of an object or a subject during an imaging procedure with an imaging device. One or more inertial measurement units (IMUs) are affixed to or embedded in the moveable portion that directly measure acceleration of translation of the moveable portion along one or more axes.

Abstract: A subject support (12) includes a fixed portion (22) and a moveable portion (11) coupled to the fixed portion and configured to move along at least one axis relative to the fixed portion (22), and the coupling includes one or more points of friction (32) that move during movement of the moveable portion (11) and which wear due to at least movement by the moveable portion (11). The moveable portion (11) receives and supports at least one of an object or a subject during an imaging procedure with an imaging device (18). One or more inertial measurement units (IMUs) (50) are affixed to or embedded in the moveable portion (11) that directly measure acceleration of translation of the moveable portion (11) along one or more axes.

Abstract: A method and apparatus for illuminating the interior of a medical imaging device is provided. The method and apparatus may convey information to the patient within the scanning tube via the use of different colors or brightness of illuminating light and images and/or text may be provided.

Abstract: Systems and methods generate a data usage plan for a mobile device. A method includes identifying a plurality of data usage requirements for the mobile device. The method includes identifying one or more carrier models for data service costs. The method includes generating cost estimates for a plurality of data usage transactions based on the data usage requirements and one or more carrier models. The method includes generating the data usage plan for the mobile device based on the cost estimates. The data usage plan includes usage parameters for carrier selection by the mobile device.

Abstract: A method and apparatus for illuminating the interior of a medical imaging device is provided. The method and apparatus may convey information to the patient within the scanning tube via the use of different colors or brightness of illuminating light and images and/or text may be provided.

Abstract: Compounds of formula (I), methods for their preparation and their use in the manufacture of neuraminidase inhibitor conjugates.

Abstract: A method of treating a patient suffering from or susceptible to ischemic heart disease, peripheral vascular disease or stroke or which subject is suffering pain, a CNS disorder or sleep apnea which comprises administering a therapeutically effective amount of an adenosine derivative which is an agonist at the adenosine A1 receptor and which exhibits little or no agonist activity of the A3 receptor.

Abstract: A method of treating a patient suffering from or susceptible to ischemic heart disease, peripheral vascular disease or stroke or which subject is suffering pain, a CNS disorder or sleep apnea which comprises administering a therapeutically effective amount of an adenosine derivative which is an agonist at the adenosine A1 receptor and which exhibits little or no agonist activity of the A3 receptor.

Abstract: A compound of formula (I) which is an agonist at the adenosine Al receptor, wherein Y, Z, and W represent heteroatoms, and salts and solvates thereof, in particular, physiologically acceptable solvates and salts thereof for use in therapy.

Abstract: A compound of formula (I) wherein R2 represents C1-3 alkyl, halogen or hydrogen; R3 represents a fluorinated straight or branched alkyl group of 1-6 carbon atoms; and salts and solvates thereof, in particular, physiologically acceptable solvates and salts thereof. These compounds are agonists of the Adenosine A1 receptor.